Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)

Name: Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)
License: Public Domain

Merck KGaA, Darmstadt, Germany

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

carcinoma lung-neoplasms

lung neoplasms, carcinoma, non-small-cell lung

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 201620
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.